Boehringer Ingelheim: Towards a better understanding of interstitial lung diseases associated with autoimmune rheumatic diseases


Amor
English
Satellite Symposium
05 June 2020 08:15 - 09:45

Objectives:

  • Discuss the role of autoimmunity and fibrosis in the pathophysiology of SSc-ILD.  
  • Consider best practice in the monitoring and management of SSc-ILD.  

  • Review new data on the management of ILD associated with autoimmune rheumatic diseases other than SSc.

 Satellite symposium available on-demand until 1 September


Presentations

Title Time Add to calendar
Welcome and introduction
05 June 2020 08:15 - 08:20 Add to calendar
Does autoimmunity drive the pathophysiology of SSc-ILD?
05 June 2020 08:20 - 08:31 Add to calendar
Do fibrotic pathways drive the pathophysiology of SSc-ILD?
05 June 2020 08:31 - 08:44 Add to calendar
Discussion: Can a better understanding of the pathophysiology of SSc-ILD help us to improve its treatment?
05 June 2020 08:44 - 08:52 Add to calendar
Optimising the monitoring and treatment of SSc-ILD
05 June 2020 08:52 - 09:03 Add to calendar
Key learnings from the SENSCIS trial
05 June 2020 09:03 - 09:17 Add to calendar
Management of ILDs associated with autoimmune rheumatic diseases (ARDs)
05 June 2020 09:17 - 09:26 Add to calendar
Discussion: Improving outcomes in patients with ILDs associated with ARDs
05 June 2020 09:26 - 09:38 Add to calendar